Posted On: 10/08/2014 12:17:21 PM
Post# of 94182

$KITE Headlines
S&P 500 ends higher for first-ever close above 2,000 4:32 p.m. Aug. 26, 2014 - Victor Reklaitis
Google buys Zync; Mobileye rallies, Orbitz falls 3:34 p.m. Aug. 26, 2014 - Angela Johnson
Kite Pharma shares fly high on study results 5:47 p.m. Aug. 25, 2014 - Wallace Witkowski
Kite Pharma shares surge 49% on drug study result 4:50 p.m. Aug. 25, 2014 - Wallace Witkowski
Costly Cancer Treatments Face Hurdles 4:25 p.m. Oct. 6, 2014 - The Wall Street Journal Interactive Edition
Kite heads north as investors pile in after CNBC highlights analyst's call 4:50 p.m. Oct. 2, 2014 - Seeking Alpha
Cramer's Mad Money - 7 Things To Watch In The Week Ahead (9/26/14) 6:08 a.m. Sept. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:14 p.m. Sept. 26, 2014 - TheStreet.com
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Kite Pharma (KITE) Shows Strength: Stock Rises 17.7% - Tale of the Tape 9:39 a.m. Aug. 27, 2014 - Zacks.com
Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog 6:44 p.m. Aug. 26, 2014 - Zacks.com
Kite Pharma's Shares Soar After Study Results 8:19 p.m. Aug. 25, 2014 - The Wall Street Journal Interactive Edition
Kite Pharma +35% following non-Hodgkin's lymphoma drug study result 5:04 p.m. Aug. 25, 2014 - Seeking Alpha
28 Venture-Capital Backed IPOs In Q2 Maintain Streak 9:49 a.m. July 8, 2014 - Investors Business Daily
IPO Market On Record Pace, Most Active Since 2000 1:02 p.m. July 2, 2014 - Investors Business Daily
IPO Stock Watch: NextEra Energy Partners IPO Strong 3:44 p.m. June 27, 2014 - Investors Business Daily
GoPro Debut Near Picture Perfect As IPO Market Booms 6:04 p.m. June 26, 2014 - Investors Business Daily
5 of the Best New Stocks of Q2 2014 3:30 a.m. June 26, 2014 - InvestorPlace.com
Company News for June 23, 2014 - Corporate Summary 10:06 a.m. June 23, 2014 - Zacks.com
IPO Stock Watch: Kite Pharma Flies High In IPO Debut 12:03 p.m. June 20, 2014 - Investors Business Daily
IPO Preview: Kite Pharma 12:29 a.m. June 20, 2014 - Seeking Alpha
IPO Stock Watch: Biotech Zafgen Up 22% On IPO Debut 4:56 p.m. June 19, 2014 - Investors Business Daily
Kite Pharma to Participate in Gene Therapy Panel at the BIO Investor Forum 6:31 p.m. Oct. 3, 2014 - GlobeNewswire
Kite Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26 12:56 p.m. Sept. 16, 2014 - GlobeNewswire
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Kite Pharma Announces Patients With Aggressive Non-Hodgkin's Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI) 4:31 p.m. Aug. 25, 2014 - GlobeNewswire
Kite Pharma Reports Second Quarter 2014 Results 5:41 p.m. Aug. 14, 2014 - GlobeNewswire
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 7:31 a.m. June 23, 2014 - GlobeNewswire
Kite Pharma, Inc. (NASDAQ: KITE) to Ring The NASDAQ Stock Market Closing Bell 10:01 a.m. June 20, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Initial Public Offering 6:00 a.m. June 20, 2014 - GlobeNewswire
S&P 500 ends higher for first-ever close above 2,000 4:32 p.m. Aug. 26, 2014 - Victor Reklaitis
Google buys Zync; Mobileye rallies, Orbitz falls 3:34 p.m. Aug. 26, 2014 - Angela Johnson
Kite Pharma shares fly high on study results 5:47 p.m. Aug. 25, 2014 - Wallace Witkowski
Kite Pharma shares surge 49% on drug study result 4:50 p.m. Aug. 25, 2014 - Wallace Witkowski
Costly Cancer Treatments Face Hurdles 4:25 p.m. Oct. 6, 2014 - The Wall Street Journal Interactive Edition
Kite heads north as investors pile in after CNBC highlights analyst's call 4:50 p.m. Oct. 2, 2014 - Seeking Alpha
Cramer's Mad Money - 7 Things To Watch In The Week Ahead (9/26/14) 6:08 a.m. Sept. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:14 p.m. Sept. 26, 2014 - TheStreet.com
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Kite Pharma (KITE) Shows Strength: Stock Rises 17.7% - Tale of the Tape 9:39 a.m. Aug. 27, 2014 - Zacks.com
Kite Pharma Drug Fares Well in Non-Hodgkin's Lymphoma Study - Analyst Blog 6:44 p.m. Aug. 26, 2014 - Zacks.com
Kite Pharma's Shares Soar After Study Results 8:19 p.m. Aug. 25, 2014 - The Wall Street Journal Interactive Edition
Kite Pharma +35% following non-Hodgkin's lymphoma drug study result 5:04 p.m. Aug. 25, 2014 - Seeking Alpha
28 Venture-Capital Backed IPOs In Q2 Maintain Streak 9:49 a.m. July 8, 2014 - Investors Business Daily
IPO Market On Record Pace, Most Active Since 2000 1:02 p.m. July 2, 2014 - Investors Business Daily
IPO Stock Watch: NextEra Energy Partners IPO Strong 3:44 p.m. June 27, 2014 - Investors Business Daily
GoPro Debut Near Picture Perfect As IPO Market Booms 6:04 p.m. June 26, 2014 - Investors Business Daily
5 of the Best New Stocks of Q2 2014 3:30 a.m. June 26, 2014 - InvestorPlace.com
Company News for June 23, 2014 - Corporate Summary 10:06 a.m. June 23, 2014 - Zacks.com
IPO Stock Watch: Kite Pharma Flies High In IPO Debut 12:03 p.m. June 20, 2014 - Investors Business Daily
IPO Preview: Kite Pharma 12:29 a.m. June 20, 2014 - Seeking Alpha
IPO Stock Watch: Biotech Zafgen Up 22% On IPO Debut 4:56 p.m. June 19, 2014 - Investors Business Daily
Kite Pharma to Participate in Gene Therapy Panel at the BIO Investor Forum 6:31 p.m. Oct. 3, 2014 - GlobeNewswire
Kite Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26 12:56 p.m. Sept. 16, 2014 - GlobeNewswire
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Kite Pharma Announces Patients With Aggressive Non-Hodgkin's Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI) 4:31 p.m. Aug. 25, 2014 - GlobeNewswire
Kite Pharma Reports Second Quarter 2014 Results 5:41 p.m. Aug. 14, 2014 - GlobeNewswire
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 7:31 a.m. June 23, 2014 - GlobeNewswire
Kite Pharma, Inc. (NASDAQ: KITE) to Ring The NASDAQ Stock Market Closing Bell 10:01 a.m. June 20, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Initial Public Offering 6:00 a.m. June 20, 2014 - GlobeNewswire


Scroll down for more posts ▼